Skip to main content
. 2023 Jun 22;9(6):e17495. doi: 10.1016/j.heliyon.2023.e17495

Fig. 2.

Fig. 2

Survival outcomes according DNA mismatch repair (MMR) protein status. A, B and C: MMR-deficient vs. -proficient tumors; D, E and F: MLH1/PMS2 loss vs. MSH2/MSH6 loss.